Andreas Wicki, Director at Harmony Biosciences Holdings, Inc. (HRMY), sold 431,174 shares at $44.14 ($19.5M) on 2022-03-11, disclosed to the SEC on 2022-03-11.
Open-market sale of $19.5M HRMY by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $45.49 | 140,000 | $6.4M | 32.7% |
| 2 | $45.80 | 75,217 | $3.4M | 17.7% |
| 3 | $45.80 | 75,217 | $3.4M | 17.7% |
| 4 | $44.14 | 70,370 | $3.1M | 16.0% |
| 5 | $44.14 | 70,370 | $3.1M | 16.0% |
| Total | $45.16 avg | 431,174 |
| $19.5M |
| 100% |
| Filing → |
| HRMY | SELL | 2022-11-16 | $6.1M | — | Filing → |
| HRMY | SELL | 2022-11-10 | $15.2M | — | Filing → |
| HRMY | SELL | 2022-11-04 | $68.2M | — | Filing → |